World Aquaculture Magazine - June 2020

48 JUNE 2020 • WORLD AQUACULTURE • WWW.WA S.ORG 5) shared and leveraged resources, 6) FDA enforcement discretion and novel approaches, and 7) development of a strategic plan for focused work. It is reasonable to assume that some aquatic animal drug approvals would have occurred whether or not the WG ever existed. However, it is hard not to conclude that the pace of actions and progress was accelerated by the activities of the WG. A collaborative approach with essential partnerships can be applied to the challenges any group may face. Acknowledgments We wish to recognize everyone who played critical roles and provided leadership throughout the 18 years of WG activities. These many individuals represented a wide diversity of expertise, organizations and associations. The mix and synergy of federal agency representatives, private industry and state public hatchery leaders, university researchers and many others created the unprecedented forces to attain many far-reaching common goals. Together they transformed the drug availability crisis into new opportunities that resulted in significant new drug label claims and aquaculture community benefits. Notes Kevin Greenlees, FDA Center for Veterinary Medicine, Senior Advisor of Science and Policy and former co-chair of WG; kevin. greenlees@fda.hhs.gov . Gary Jensen, retired former National Program Leader for Aquaculture, USDANational Institute of Food and Agriculture, former Chair of Joint Subcommittee on Aquaculture and past co- chair of WG; gljensen7@gmail.com. Jennifer Matysczak, FDA Center for Veterinary Medicine, Office of NewAnimal Drug Evaluation, Aquaculture Drugs Team Leader and member of the Subcommittee of Aquaculture; jennifer. matysczak@fda.hhs.gov . Rosalie Schnick, retired former Technical Information Specialist and Registration Officer at FWS and USGS Upper Midwest Environmental Sciences Center and former National Aquaculture NewAnimal Drug Application Coordinator; RozSchnick@ centurytel.net . Gary Stefan, retired former Chief of Industry Programs Branch at FDA Center for Veterinary Medicine and first chair of WG; ingary@msn.com. References American Fisheries Society Fish Culture Section. 2011. Guide to Using Drug, Biologics and other Chemicals in Aquaculture. Bowker, J.D., J.T. Trushenski, M.P. Gaikowski and D.L. Straus, editors. 2016. Guide to Using Drugs, Biologics and other Chemicals in Aquaculture. American Fisheries Society Fish Culture Section. pp. 64. Bowker, J.D. and J.T. Trushenski, editors. 2019. Guide to Using Drugs, Biologics and other Chemicals in Aquaculture. American Fisheries Society Fish Culture Section. pp. 81. Catfish Farmers of America. 1993. Catfish Quality Assurance. pp. 14 Jahncke, M.L., Smith, T.I.J. and B. Sheehan. 1996. The Striped Bass Industry from Fish Farm to Consumer. South Carolina Marine Resources Center Educational Report No. 18. Jensen, G. 1993. Quality Assurance in Aquaculture. Waterlines Vol 5(1):5. Jensen, G. 1998a. Monitoring aquaculture uses of drugs, chemicals and pesticides in HACCP. World Aquaculture Book of Abstracts No. 308. Jensen, G. 1998b. Bibliography of resource material on HACCP and quality assurance for the aquaculture sector. Salmonid Vol. XXII, No. 1:18-22. Jensen, G. 1998c. Challenges and opportunities with international harmonization of aquaculture therapeutants. World Aquaculture Society Book of Abstracts No. 307. McCraren, J. P. 1995. Current Status of USFTA and NAA’s Producer Quality Assurance Plans, Salmonid XIX(3):8-9. National Agricultural Library. 1992. Federal regulation of drugs, biologicals, and chemicals used in aquaculture production. Joint Subcommittee on Aquaculture Working Group on Quality Assurance in Aquaculture Production, pp. 123. Schnick, R.A. 1999. Use of chemicals in fish management and fish culture: past and future. Chapter 1, pages 1-14 in D.J. Smith, W.H. Gingerich, and M.G. Beconi-Barker, eds. Xenobiotics in Fish. Kluwer Academic/ Plenum Publishers, NewYork. Schnick, R.A. 2011. Approved drugs and unmet needs in the US. Pages 1-6 in Aquaculture, Proceedings of the American Academy of Veterinary Pharmacology and Therapeutics 17 th Biennial AAVPT Symposium: All Molecules Great and Small. Schnick, R.A. and R.D. Armstrong. 1997. Aquaculture drug approval progress in the United States. Northern Aquaculture Supplement (Salmon Health Report):22-28. Schnick, R. A., W.H. Gingerich, and K.H. Koltes. 1996. Federal-State Aquaculture Drug Registration Partnership: A success story in the making. Fisheries 21(5):4. Texas Agricultural Extension Service. 1994. Guide to Drug, Vaccine, and Pesticide Use in Aquaculture . Texas A&MUniversity for Joint Subcommittee on Aquaculture, 68 pp. United States Trout Farmers Association. 1994. Trout Producer Quality Assurance Program, 28 pp. For 18 years, the WG provided an unequaled mechanism for coordinating the efforts of federal and state agencies, academic institutions, drug companies, aquaculture enterprises and private individuals to increase the legal availability and proper use of animal drugs, biologics and pesticides in aquaculture production. More compounds were approved for aquatic animal use per year during its existence than before it formed or after it disbanded. The unlikely mix of government, industry and academia representatives found common ground in their joint determination to overcome tremendous obstacles and assure that US aquaculture would have approved animal drugs, biologics and pesticides for use in the production of safe and wholesome food for American consumers.